HRT FINANCIAL LP sold $49K of BJDX
HRT FINANCIAL LP sold 34,938 shares of Bluejay Diagnostics, Inc. (BJDX) at $1.40 on 2026-07-10.
How this was made
The 30-second read
Why it matters
The newest fact is the reported open-market sale by a 10% owner at a specified price and share count; it may influence short-term sentiment but does not change operating outlook based on the provided text.
Market read
Traders may monitor for follow-on insider activity or interpret the sale as mild negative sentiment, but there is no new fundamental catalyst in the text.
What to watch
No 10b5-1 plan is stated, but the article also lacks context on total holdings, prior sales cadence, or whether the sale was part of broader portfolio rebalancing.
Background
This is an SEC Form 4 insider transaction disclosure for Bluejay Diagnostics, Inc. (BJDX).
Ticker impact
HRT Financial LP, a 10% owner, filed a Form 4 selling 34,938 BJDX shares at $1.40 on 2026-07-10.
Likely limited near-term impact; any effect should be small and sentiment-driven.
The filing is a routine insider sale with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, trials, deals). Size is moderate, so impact is usually contained.
Market effects
No sector read-across; this is a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
The sale may be liquidity-driven and not a bearish signal, especially since the filing provides no rationale or linkage to company performance.
Key entities
- issuerBluejay Diagnostics, Inc.
Subject of the Form 4 insider sale disclosure (BJDX).
- insiderHRT Financial LP
10% owner who sold 34,938 shares in an open-market transaction.
- filingSEC Form 4
Primary-source insider transaction report filed on 2026-07-13.
